Reduced number of peripheral natural killer cells in schizophrenia but not in bipolar disorder-Reference-Cited by-同舟云学术

Reduced number of peripheral natural killer cells in schizophrenia but not in bipolar disorder

Published:2016-05 Issue: Volume:54 Page:194-200
ISSN:0889-1591
Container-title:Brain, Behavior, and Immunity
language:en
Short-container-title:Brain, Behavior, and Immunity

Author:

Karpiński Paweł,Frydecka Dorota,Sąsiadek Maria M.,Misiak Błażej

Funder

Foundation for Polish Science

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Endocrine and Autonomic Systems,Immunology

Reference67 articles.

1. Deconvolution of blood microarray data identifies cellular activation patterns in systemic lupus erythematosus;Abbas;PLoS ONE,2009

2. Immunological changes in patients with mania: changes in cell mediated immunity in a sample from Egyptian patients;Abeer;Egypt. J. Immunol.,2006

3. Monocyte and lymphocyte activation in bipolar disorder: a new piece in the puzzle of immune dysfunction in mood disorders;Barbosa;Int. J. Neuropsychopharmacol.,2015

4. NCBI GEO: archive for functional genomics data sets – update;Barrett;Nucleic Acids Res.,2013

5. The influence of olanzapine on immune cells in patients with schizophrenia;Bilici;Prog. Neuropsychopharmacol. Biol. Psychiatry,2003

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coping styles do not interact with the association between childhood trauma history and the immune-inflammatory phenotype of schizophrenia: Findings from a cross-sectional study;Psychoneuroendocrinology;2024-08

2. Immunophenotypes in psychosis: is it a premature inflamm-aging disorder?;Molecular Psychiatry;2024-03-26

3. The Role of Innate and Adaptive Immune System in the Pathogenesis of Schizophrenia;Iranian Journal of Allergy, Asthma and Immunology;2024-02-20

4. Natural killer (NK) cells in bipolar disorders;Neuroscience Applied;2024

5. Inflammation and Mental Health Disorders: Immunomodulation as a Potential Therapy for Psychiatric Conditions;Current Pharmaceutical Design;2023-11